Pune-based healthtech startup CureMeAbroad has secured $600,000 in a pre-seed funding round backed by a powerful syndicate of angel investors. The cap table for this early round features notable founders and operators, including Unacademy co-founder Roman Saini, former Cars24 India CEO Himanshu Ratnoo, EMotorad CEO Kunal Gupta, Moonshot co-founder Devaiah Bopanna, IAVC founder Vikrant Potnis, and AIRA Buildon. Co-founded in June 2025 by Aditya Oza and Mikhail Bohra, the startup operates an AI-first discovery platform that connects international patients with verified hospitals, surgeons, and healthcare destinations. The fresh capital injection will be deployed toward strengthening its core technology stack, specifically expanding its proprietary AI cost estimator, refining clinical matching models, and building out a multilingual patient intelligence layer.
The core bottleneck in the medical tourism industry has always been trust and pricing opacity. For decades, international patients seeking affordable, high-quality care have been forced to navigate a fragmented market heavily reliant on local brokers, unverified static directories, and opaque WhatsApp-based agents who prioritize commission over clinical outcomes. CureMeAbroad addresses this exact friction point by operating as a highly structured, data-driven discovery engine. The platform leverages a proprietary AI cost estimator trained on over 600 specific procedure records, allowing patients from high-cost markets like the US, UK, and GCC to accurately project expenses across key hubs such as Mexico, Turkey, Thailand, and India. Instead of using aggressive "book now" sales tactics, the startup focuses on consultative matching and comparison. With an initial self-funded base of ₹3 crore, the founders have already scaled operations aggressively, reportedly crossing an annualized revenue run rate of $3.5 million within their first two quarters.
This funding event highlights a critical maturation point for cross-border healthcare logistics. The global medical tourism market is projected to reach $174 billion over the next decade, yet the infrastructure connecting patient demand to hospital supply remains remarkably archaic. By integrating an AI layer and maintaining strict HIPAA compliance, CureMeAbroad is building a defensible data moat that traditional concierge services and travel agents simply cannot replicate. For global hospital chains, this platform standardizes international patient acquisition, potentially driving down customer acquisition costs (CAC) while ensuring higher conversion rates through verified, high-intent leads. If CureMeAbroad successfully normalizes its technology-first approach across varied geographies and languages, it will force legacy players to either digitize their pricing models or risk losing access to the lucrative pipeline of inbound international patients.
For daily, sharp analysis of the biggest moves in the Indian business and startup ecosystem, follow StartupFox.